结构性种族主义是急性髓系白血病预后差异的中介因素
该研究对来自6个城市癌症中心的822例成人急性髓系白血病(AML)患者进行离散生存分析,发现非西班牙裔黑人(NHB)患者生存劣于非西班牙裔白人(NHW)患者(HR=1.59;95%CI:1.15,2.22),西班牙裔患者HR=1.25(95%CI:0.88,1.79)。中介分析显示,普查区结构性种族主义指标几乎解释了全部NHB-NHW和西班牙裔-NHW的白血病死亡差异。
要点
- NHB患者AML生存劣于NHW患者(HR=1.59;95%CI:1.15,2.22)。
- 西班牙裔患者AML生存与NHW患者相比HR=1.25(95%CI:0.88,1.79)。
- 普查区结构性种族主义指标几乎解释了全部NHB-NHW和西班牙裔-NHW的白血病死亡差异。
核心结论
- 普查区结构性种族主义指标几乎解释了全部NHB-NHW和西班牙裔-NHW的白血病死亡差异。
- 治疗模式(诱导强度和异基因移植)及诱导化疗期间ICU入住是AML生存差异的额外中介因素。
- 这是首个正式检验AML生存差异中介因素的研究,强调需探究结构性种族主义与已知预后及治疗因素交互影响白血病结局的机制。
研究设计与样本
- 对来自6个城市癌症中心的822例成人AML患者进行离散生存分析。
- 随后进行多水平分析,探讨社区结构性种族主义指标对种族/民族生存差异的贡献。
- 分别计算普查区劣势评分和富裕评分。
- 通过6个复合变量检验组间白血病死亡风险的中介效应:结构性种族主义(普查区劣势、富裕和隔离)、肿瘤生物学(欧洲白血病网络风险和第二白血病)、医疗可及性(保险和临床试验入组)、合并症、治疗模式(诱导强度和移植利用)以及诱导化疗期间ICU入住。
主要发现
- NHB患者生存劣于NHW患者(HR=1.59;95%CI:1.15,2.22)。
- 西班牙裔患者生存与NHW患者相比HR=1.25(95%CI:0.88,1.79)。
- 普查区指标几乎解释了全部NHB-NHW和西班牙裔-NHW的白血病死亡差异。
- 治疗模式(包括诱导强度和异基因移植)及诱导化疗期间ICU入住是AML生存差异的额外中介因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-Hispanic Black (NHB) and Hispanic patients with acute myeloid leukemia (AML) have higher mortality rates than non-Hispanic White (NHW) patients despite more favorable genetics and younger age. A discrete survival analysis was performed on 822 adult patients with AML from 6 urban cancer centers and revealed inferior survival among NHB (hazard ratio [HR] = 1.59; 95% confidence interval [CI]: 1.15, 2.22) and Hispanic (HR = 1.25; 95% CI: 0.88, 1.79) patients compared with NHW patients. A multilevel analysis of disparities was then conducted to investigate the contribution of neighborhood measures of structural racism on racial/ethnic differences in survival. Census tract disadvantage and affluence scores were individually calculated. Mediation analysis of hazard of leukemia death between groups was examined across 6 composite variables: structural racism (census tract disadvantage, affluence, and segregation), tumor biology (European Leukemia Network risk and secondary leukemia), health care access (insurance and clinical trial enrollment), comorbidities, treatment patterns (induction intensity and transplant utilization), and intensive care unit (ICU) admission during induction chemotherapy. Strikingly, census tract measures accounted for nearly all of the NHB-NHW and Hispanic-NHW disparity in leukemia death. Treatment patterns, including induction intensity and allogeneic transplant, and treatment complications, as assessed by ICU admission during induction chemotherapy, were additional mediators of survival disparities in AML. This is the first study to formally test mediators for observed disparities in AML survival and highlights the need to investigate the mechanisms by which structural racism interacts with known prognostic and treatment factors to influence leukemia outcomes.
引用
- Abraham IE, Rauscher GH, Patel AA, et al. Structural racism is a mediator of disparities in acute myeloid leukemia outcomes. Blood. 2022. PMID: 35061876. doi:10.1182/blood.2021012830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。